NASDAQ:BBHVanEck Vectors Biotech ETF Stock Price, Forecast & News

VanEck Vectors Biotech ETF's stock was trading at $126.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BBH stock has increased by 31.8% and is now trading at $167.13. View which stocks have been most impacted by Coronavirus.

Headlines about BBH stock have been trending somewhat positive on Sunday, according to InfoTrie. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. VanEck Vectors Biotech ETF earned a daily sentiment score of 1.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about VanEck Vectors Biotech ETF.

Some companies that are related to VanEck Vectors Biotech ETF include Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), Tri-Continental (TY), Gabelli Equity Trust (GAB), Liberty All-Star Equity Fund (USA), Royce Value Trust (RVT), Hercules Capital (HTGC), Boulder Growth & Income Fund (BIF), Blackrock Muniyield Insured Fund (MYI), Tekla Healthcare Investors (HQH), AllianceBernstein Global Hgh Incm Fd (AWF), Tortoise Energy Infrastructure (TYG), Invesco Van Kampen Munpl Oprtnty Tr (VMO), General American Investors (GAM) and Templeton Dragon Fund (TDF). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Vectors Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Marina Biotech (MRNA), Sanofi (SNY), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Crispr Therapeutics (CRSP), Johnson & Johnson (JNJ), Matinas BioPharma (MTNB) and Micron Technology (MU).

VanEck Vectors Biotech ETF trades on the NASDAQ under the ticker symbol "BBH."

VanEck Vectors Biotech ETF's stock is owned by many different retail and institutional investors. Top institutional investors include Envestnet Asset Management Inc. (0.62%), LFA Lugano Financial Advisors SA (0.29%) and Hummer Financial Advisory Services Inc (0.05%).

BBH stock was acquired by a variety of institutional investors in the last quarter, including LFA Lugano Financial Advisors SA, Envestnet Asset Management Inc., and Hummer Financial Advisory Services Inc.

Shares of BBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BBH stock can currently be purchased for approximately $167.13.

VanEck Vectors Biotech ETF has a market capitalization of $509.75 million.